Drug delivery to the retina: challenges and opportunities. - Wikidata - wikimedia - TriplyDB

Drug delivery to the retina: challenges and opportunities.

Drug delivery to the retina: challenges and opportunities.

http://www.wikidata.org/entity/Q35116140

about

Strategies on the nuclear-targeted delivery of genes Targeted and reversible blood-retinal barrier disruption via focused ultrasound and microbubbles Development of a Δ9-Tetrahydrocannabinol Amino Acid-Dicarboxylate Prodrug With Improved Ocular Bioavailability.Solid lipid nanoparticles for ocular drug delivery.Interaction between topically and systemically coadministered P-glycoprotein substrates/inhibitors: effect on vitreal kinetics.The potential of nanomedicine therapies to treat neovascular disease in the retina.Tower microneedle via reverse drawing lithography for innocuous intravitreal drug delivery.Sustained subconjunctival protein delivery using a thermosetting gel delivery system.Novel nanoparticulate gel formulations of steroids for the treatment of macular edema.Muscarinic receptors: their distribution and function in body systems, and the implications for treating overactive bladder Progress in Small Molecule Therapeutics for the Treatment of Retinoblastoma.Folic acid transport via high affinity carrier-mediated system in human retinoblastoma cells.Ophthalmic drug delivery considerations at the cellular level: drug-metabolising enzymes and transporters.Evaluation of the intravenous and topical routes for ocular delivery of hesperidin and hesperetin.Phase I and phase II ocular metabolic activities and the role of metabolism in ophthalmic prodrug and codrug design and delivery.Sustained transscleral drug delivery.MRI in ocular drug delivery.Noninvasive molecular neuroimaging using reporter genes: part II, experimental, current, and future applications.Defining targets for investigating the pharmacogenomics of adverse drug reactions to antifungal agents.Recent perspectives in ocular drug delivery.Vitreal kinetics of quinidine in rabbits in the presence of topically coadministered P-glycoprotein substrates/modulators.Polymeric vectors for ocular gene delivery.Recent overview of ocular patents Strategies for ocular siRNA delivery: Potential and limitations of non-viral nanocarriers.Intravitreal devices for the treatment of vitreous inflammation.Ocular Drug Delivery; Impact of in vitro Cell Culture Models.Nanotechnology approaches for ocular drug delivery.Advances in the understanding of retinal drug disposition and the role of blood-ocular barrier transporters.Impacts of nanomedicines in ocular pharmacotherapy Microemulsion: new insights into the ocular drug delivery.Drug delivery implants in the treatment of vitreous inflammation Topical delivery of ocular therapeutics: carrier systems and physical methods.Advances in ocular drug delivery: emphasis on the posterior segment.Application of lipid nanoparticles to ocular drug delivery.Current treatment strategies and nanocarrier based approaches for the treatment and management of diabetic retinopathy.Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo Diffusion Regulation in the Vitreous Humor.Solution formulation development of a VEGF inhibitor for intravitreal injection.Synthesis of taurine-fluorescein conjugate and evaluation of its retina-targeted efficiency in vitro.Dendrimers for Ocular Drug Delivery.

P2860

Q26852376-5BD1DC80-C5E0-4DAA-B424-A5F2048BE218 Q28482229-E6712506-365B-4543-8C22-6807C9D721AB Q33558455-3FEF754A-8455-4460-B797-255DD3202AF6 Q34116807-86546DCA-8611-42F8-8D31-8301D755E375 Q34211061-5D9F735F-6F2F-41CA-8419-A35A98CEE268 Q34220590-0A4A0EA1-24E7-45A1-B269-24D406F591F0 Q34499190-042A61F7-38E6-4E73-B908-CA94CECCA849 Q34987321-781F0065-8C51-4019-AF08-25E5421A20D7 Q34987327-5226F126-E711-4BAB-BEAD-2E99C7A1956E Q35546189-E9548A10-4752-41CC-B068-F8F7FA482AF1 Q35706804-04518EA9-2F1E-4942-824D-3FA1828DA990 Q35892580-691FE652-5367-4E36-8E92-2F8591663EBA Q36316835-44CED232-1F91-423E-BB0E-5E12C76D3942 Q36421799-F1B06FDC-452B-401D-BFC1-7C5B88BC0858 Q36939218-9FC92091-DFE3-4C2A-94C3-A28B13E9EF2E Q37039016-0BAC1239-2AFB-423F-8DDA-A022CDAAB023 Q37054230-934E93FD-7725-4086-9B08-8BFA15FB730A Q37083995-BE502776-B994-4F06-9FBD-A7B2274AECA2 Q37157893-FC9A445A-93E4-4798-BD3E-022AED2C9E82 Q37256549-72BD3B55-AB91-4FFF-918F-FFF4801AE9A9 Q37266286-DA398002-2ECD-4F0B-8E10-AE842EE84779 Q37920729-69214A1F-79D8-45D4-B5E7-B5174D527D6F Q38001747-B5733E4F-5F7C-4C0A-BE05-390666DF4A69 Q38017713-A87FA7BD-38AD-473D-B601-1CBD91120AEF Q38044373-EBADCCAE-FD60-48B2-8840-26D4A45B8850 Q38063860-0FE60129-9265-4909-9503-9593767DC427 Q38098509-3F6A31D5-6DB5-4B96-9F6B-D8F3EB5111ED Q38104396-4DD7F2E7-B233-4B66-9685-5EC28D5279D1 Q38107200-EBB37644-D3DC-4F2F-B791-55AF14E74A60 Q38128310-0B45F746-D977-452F-8985-F895C6D03FA8 Q38160003-DDFED449-4B38-4607-AA5F-DE45E00DD476 Q38196446-F8CBF56F-AF7F-4F73-9D59-5609C3E3C84D Q38224320-ADE51ADF-E637-4E3F-886E-8C33174DE4B7 Q38862505-1C23D55A-954D-40A6-9E4F-81EE6D4B95B9 Q39103248-56B433CA-5888-4D11-A623-67BB470A942C Q41587469-D6B59C08-634C-45A4-9D19-B46BE7BD0613 Q41946889-EAD78789-9CD1-4854-98F6-FE15A283CEEE Q42705638-7B6A990B-7087-4D27-AC2E-812ADC3517EF Q43193542-4899B75A-E9EF-4833-B38B-84339A7FFD1A Q45073183-467DD215-590A-4893-9CF3-32235E1DAA36

P2860

Drug delivery to the retina: challenges and opportunities.

http://www.wikidata.org/entity/Q35116140

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Drug delivery to the retina: challenges and opportunities.

@ast

Drug delivery to the retina: challenges and opportunities.

@en

type

label

Drug delivery to the retina: challenges and opportunities.

@ast

Drug delivery to the retina: challenges and opportunities.

@en

prefLabel

Drug delivery to the retina: challenges and opportunities.

@ast

Drug delivery to the retina: challenges and opportunities.

@en

P1433

Q35116140-F42CCD80-FFC5-4E11-AADB-2E6711A5B37F

P1476

Q35116140-8CA12BD9-086F-45FA-9F65-09968E5D107C

P2093

Q35116140-381ABF56-7D57-47C1-BDC0-C4807ACACFA7

Q35116140-87E609DF-0E8A-46A0-A91E-1496038C5FE0

Q35116140-FF31306F-6552-4D98-B64D-809B2D826980

P2860

Q35116140-0B555F77-353B-48A9-9D56-F41F7ADB4497

Q35116140-0D3F801A-827C-4510-89ED-4FD216BA3850

Q35116140-0F9E0B5C-D7D6-4882-A420-B9C4E5DC78BB

Q35116140-19626165-8E50-4EFD-AA86-D0C68FDDC4F7

Q35116140-1C5B1BF9-C9DA-4023-ABFF-7E7C51F61309

Q35116140-2585BE2A-E775-4452-B63C-9071861D0DE8

Q35116140-2E7CFC49-1160-496B-B709-0AFDECE42871

Q35116140-2FFCE313-7B2D-435B-A769-B21BC2A1D8B9

Q35116140-31749161-7295-494E-A511-781B2F52E0CA

Q35116140-3422BE37-AC2C-4E81-846B-9C3B84746941

P304

Q35116140-6ADA4EB7-DFB2-4154-B57D-E1F05E328295

P31

Q35116140-317D0CE8-2AD3-4445-8A4C-C831ABA20222

P356

Q35116140-95994588-C8CD-4F79-9070-5DF52953BAE5

P407

Q35116140-5BD936B5-ACB9-4F37-83C2-9EA0178BF217

P433

Q35116140-EF584FBE-8410-444D-B839-BDBF953286D4

P478

Q35116140-DF880604-4078-404C-87D1-3CB05CA5ED91

P577

Q35116140-F77E6D65-7188-4D97-9663-975ED604EE07

P698

Q35116140-45DD8AF0-1697-4908-8582-561F677432CA

P921

Q35116140-7BEADAC3-B2F7-4C7C-B256-80A1F99C2C57

P356

14712598.3.1.45

P1433

Expert Opinion on Biological Therapy

P1476

Drug delivery to the retina: challenges and opportunities.

@en

P2093

Ashim K Mitra

http://www.w3.org/2001/XMLSchema#string

Soumyajit Majumdar

http://www.w3.org/2001/XMLSchema#string

Sridhar Duvvuri

http://www.w3.org/2001/XMLSchema#string

P2860

The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation

Importance of a small N-terminal region in mammalian peptide transporters for substrate affinity and function

Valganciclovir results in improved oral absorption of ganciclovir in liver transplant recipients

Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1

Nasal absorption of tyrosine-linked model compounds.

Ocular pharmacokinetics in rabbits using a novel dual probe microdialysis technique.

Peptide transport in the mammary gland: expression and distribution of PEPT2 mRNA and protein.

Carrier-mediated membrane transport of folates in mammalian cells.

Targeted drug delivery via the folate receptor.

Influence of amino acid side-chain modification on the uptake system for beta-lactam antibiotics and dipeptides from rabbit small intestine.

P304

45-56

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14712598.3.1.45

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12718730

http://www.w3.org/2001/XMLSchema#string

P921